DANIEL G WELCH Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for DANIEL G WELCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL G WELCH. DANIEL G WELCH is CEO and President in INTERMUNE INC ($ITMN) and Chairman, CEO and President in INTERMUNE INC ($ITMN) and President & CEO in INTERMUNE INC ($ITMN) and President and CEO in INTERMUNE INC ($ITMN) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in HYPERION THERAPEUTICS INC ($HPTX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in AveXis, Inc. ($AVXS) and Director in Nuvation Bio Inc. ($PANA).
DANIEL G WELCH in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL G WELCH: Director
Holdings: 65,348 shares
Current Value: $3,972,505
Latest Transaction: Nov 04 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL G WELCH in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVXS, HPTX, ICPT, ITMN, NUVB, SGEN, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 36.70 | 8,750 | 321,125 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 34.25 | 8,750 | 299,688 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 9,518 | 190,931 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 20.06 | 7,982 | 160,119 | 9,518 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Option Exercise | M | 19.02 | 14,500 | 275,790 | 0 | |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 164.61 | 9,250 | 1,522,643 | 47,348 | 56.6 K to 47.3 K (-16.34 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.06 | 14,500 | 2,393,370 | 56,598 | 71.1 K to 56.6 K (-20.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 19.02 | 14,500 | 275,790 | 71,098 | 56.6 K to 71.1 K (+25.62 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 165.72 | 9,518 | 1,577,323 | 56,598 | 66.1 K to 56.6 K (-14.40 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 9,518 | 190,931 | 66,116 | 56.6 K to 66.1 K (+16.82 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 166.70 | 7,982 | 1,330,599 | 56,598 | 64.6 K to 56.6 K (-12.36 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 20.06 | 7,982 | 160,119 | 64,580 | 56.6 K to 64.6 K (+14.10 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 167.34 | 8,750 | 1,464,225 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 36.70 | 8,750 | 321,125 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Sell | S | 168.24 | 8,750 | 1,472,100 | 56,598 | 65.3 K to 56.6 K (-13.39 %) |
Nov 04 2020 | SGEN | Seagen Inc. | WELCH DANIEL G | Director | Buy | M | 34.25 | 8,750 | 299,688 | 65,348 | 56.6 K to 65.3 K (+15.46 %) |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
May 19 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,335 | 0 | 56,598 | 55.3 K to 56.6 K (+2.42 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.77 | 205 | 34,188 | 55,263 | 55.5 K to 55.3 K (-0.37 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.23 | 2,435 | 404,770 | 55,468 | 57.9 K to 55.5 K (-4.21 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 164.98 | 4,319 | 712,549 | 57,903 | 62.2 K to 57.9 K (-6.94 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 164.21 | 8,041 | 1,320,413 | 62,222 | 70.3 K to 62.2 K (-11.44 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 167.99 | 284 | 47,709 | 70,263 | 70.5 K to 70.3 K (-0.40 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 167.26 | 11,011 | 1,841,700 | 70,547 | 81.6 K to 70.5 K (-13.50 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 166.27 | 5,400 | 897,858 | 81,558 | 87 K to 81.6 K (-6.21 %) |
May 07 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Sell | S | 165.62 | 3,305 | 547,374 | 86,958 | 90.3 K to 87 K (-3.66 %) |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 12.76 | 17,500 | 223,300 | 0 | |
Jan 09 2020 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 12.76 | 17,500 | 223,300 | 90,263 | 72.8 K to 90.3 K (+24.05 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 64.38 | 7,038 | 453,106 | 7,038 | |
May 22 2019 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 2,963 | 0 | 72,763 | 69.8 K to 72.8 K (+4.24 %) |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 22 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 69,800 | 66.1 K to 69.8 K (+5.60 %) |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 8.38 | 6,881 | 57,663 | 0 | |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 8.38 | 6,881 | 57,663 | 66,100 | 59.2 K to 66.1 K (+11.62 %) |
Feb 15 2018 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 10.08 | 10,000 | 100,800 | 59,219 | 49.2 K to 59.2 K (+20.32 %) |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 49,219 | 45.5 K to 49.2 K (+8.13 %) |
May 24 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 38.82 | 9,260 | 359,473 | 9,260 | |
May 24 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 45,519 | 41.8 K to 45.5 K (+8.85 %) |
Mar 10 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | M | 9.82 | 25,000 | 245,500 | 0 | |
Mar 10 2016 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Buy | M | 9.82 | 25,000 | 245,500 | 41,819 | 16.8 K to 41.8 K (+148.64 %) |
May 19 2015 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 39.94 | 9,260 | 369,844 | 9,260 | |
May 19 2015 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 16,819 | 13.1 K to 16.8 K (+28.20 %) |
Page: 1